Trading Signals
Kintara Therapeutics, Inc. (KTRA) Stock on a Steep Rise, Here’s Why
Kintara Therapeutics, Inc. (KTRA), a clinical-stage drug development company, closed Monday’s regular trading session at $0.50 after rocketing by 35.41% during the day. In the aftermarket, KTRA stock has further surged by 3.43% and as a result, is trading at $0.52 at the time of the writing. KTRA Presented Data KTRA stock rose on Monday following the announcement regarding the presentation of data. On Monday, the company announced that it had presented the data at the 2022 American Association for Cancer Research (AACR) Annual Meeting. The presentation discussed the impact of Dianhydrogalactitol (VAL-083) on the treatment of Glioblastoma Multiforme (GBM). An
